Stay updated on Risankizumab in Psoriatic Arthritis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab in Psoriatic Arthritis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added publication Gossec L., et al., 'Efficacy of Risankizumab across distinct PsA phenotypes identified with machine learning analytics using data from biologic DMARD-Naive patients in two phase 3 clinical trials' (Arthritis Res Ther. 2025) and updated the revision to v3.3.2; removed v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:15:18.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Added clarifications that publications are provided voluntarily by the study submitter and may be drawn from PubMed, and that entries may not all pertain to the study. Updated the revision version to v3.3.1.
    Difference
    0.1%
    Check dated 2025-11-24T13:32:15.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-17T06:28:51.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The screenshots show only formatting/layout adjustments and the location list; no core study information or criteria appear to be altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T01:10:51.000Z thumbnail image
  5. Check
    65 days ago
    Change Detected
    Summary
    Updated page includes an authoritatively updated operating status notice and a new clinical-trial citation, plus a version bump from v3.1.0 to v3.2.0; prior version tag removed.
    Difference
    3%
    Check dated 2025-10-05T10:06:58.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Introduced Revision: v3.1.0 and removed several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) along with the older Revision: v3.0.2, signaling a content pruning and a new version update.
    Difference
    0.2%
    Check dated 2025-09-28T03:11:58.000Z thumbnail image

Stay in the know with updates to Risankizumab in Psoriatic Arthritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab in Psoriatic Arthritis Clinical Trial page.